D. Gill

发表

Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine

D. Ho, Zhiwei Chen, A. Hurley, 2010, PloS one.

Title Phase I safety and immunogenicity evaluation of ADVAX , aMultigenic , DNA-based Clade C / B ' HIV-1 candidate vaccine

D. Ho, Zhiwei Chen, A. Hurley, 2010 .

Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia.

J. Best, J. Cason, D. Gill, 1998, The Journal of general virology.

Antigen Society #6 Report (B21, B49, Bw50, BN21, B12, B44, B45)

D. Gill, J. E. Mcauley, K. Mittal, 1989 .

Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories

S. Self, P. Kaleebu, R. Koup, 2010, PloS one.

The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania

R. Hayes, C. Lacey, H. Weiss, 2001, Sexually transmitted infections.

A DNA-Based Candidate HIV Vaccine Delivered via In Vivo Electroporation Induces CD4 Responses toward the α4β7-Binding V2 Loop of HIV gp120 in Healthy Volunteers

S. Vasan, P. Hayes, J. Cox, 2012, Clinical and Vaccine Immunology.

In Vivo Electroporation Enhances the Immunogenicity of an HIV-1 DNA Vaccine Candidate in Healthy Volunteers

Jill Gilmour, Sandhya Vasan, D. Ho, 2011, PloS one.

Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates.

B. Walker, E. Karita, O. Anzala, 2010, The Journal of infectious diseases.

Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents

P. Kaleebu, O. Anzala, J. Birungi, 2008, Clinical and Vaccine Immunology.

Safety and Immunogenicity of DNA Prime and Modified Vaccinia Ankara Virus-HIV Subtype C Vaccine Boost in Healthy Adults

B. Gazzard, G. Alter, M. Boffito, 2013, Clinical and Vaccine Immunology.

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

J. Excler, P. Fast, P. Hayes, 2012, PloS one.

Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine

Yang Song, Soe Than, Martin Ho, 2010, PloS one.

Broad HIV Epitope Specificity and Viral Inhibition Induced by Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

J. Excler, J. Czyzewska-Khan, P. Fast, 2014, PloS one.

Genital Human Papillomavirus Genotypes in Northwestern Tanzania

C. Lacey, H. Weiss, D. Mabey, 2003, Journal of Clinical Microbiology.

Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials.

Frances Gotch, Peter Kelleher, Ambreen Ashraf, 2011, Journal of immunological methods.

Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine

D. Ho, Zhiwei Chen, A. Hurley, 2010, PloS one.

Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine

G. Zaharatos, P. Fast, J. Cox, 2010, PloS one.